Cardiovascular and Neurohormonal Effects of Faster Atrial Pacing Rate

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Heart Failure
Interventions
DEVICE

Medtronic Pacemaker

Patients will come to clinic in the morning for baseline measurements. Subsequently, the atrial pacing rate will be increased to 85bpm for 6 hours. The control group will be given the illusion that their pacer has been adjusted, but the settings will remain unchanged. Patients will eat a standard breakfast provided by the hospital prior to the treatment session, and then will fast for the six-hour observation period. Patients will remain in supine position and will be clinically monitored for 6 hours. All patients will be on continuous cardiac monitors. Vital signs and symptoms of congestion/ischemia will be recorded every hour.

Trial Locations (1)

10032

Columbia University, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Columbia University

OTHER

NCT00698139 - Cardiovascular and Neurohormonal Effects of Faster Atrial Pacing Rate | Biotech Hunter | Biotech Hunter